DGX insider filings
QUEST DIAGNOSTICS INC — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-16. Screen DGX transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 18 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 17 legs across 6 filings by 6 insiders — 79,478 shares, $19,794,069 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
- Largest priced transaction: sale of 16,010 shares @ $242.88 ($3,888,437) by PREVOZNIK MICHAEL E, filed 2026-08-31.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| PREVOZNIK MICHAEL E — SVP & General Counsel | 1 | — | 3 legs · 22,677 sh · $5,513,083 | 3 |
| Doherty Catherine T. — Executive Vice President | 1 | — | 7 legs · 22,105 sh · $5,482,442 | 3 |
| Deppe Michael J — SVP, Corp. Controller & CAO | 1 | — | 2 legs · 11,776 sh · $3,063,762 | 4 |
| Plewman Patrick — SVP for Diagnostic Services | 2 | — | 3 legs · 11,717 sh · $3,015,253 | 5 |
| Davis J. E. — CEO and President, Director | 1 | — | 1 leg · 10,000 sh · $2,427,200 | — |
| PFEIFFER GARY M — Director | 1 | — | 1 leg · 1,203 sh · $292,329 | — |
| DELANEY MARK E — SVP & Chief Commercial Officer | 2 | — | — | 2 |
| Ramachandran Subu — SVP, Regional Businesses | 2 | — | — | 2 |
| CARTER ROBERT B — Director | 1 | — | — | 1 |
| Gregg Vicky B — Director | 1 | — | — | 1 |
+5 more insiders in the window, not shown — every filing appears in the table below.
Recent insider filings — QUEST DIAGNOSTICS INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-16 | 4 | Deppe Michael J — SVP, Corp. Controller & CAO | Option exercise (M): 6,261 @ $95.80 · Sale (S): 6,261 @ $260.17 · Option exercise (M): 5,515 @ $103.57 · Sale (S): 5,515 @ $260.17 · Option exercise (M): 6,261 (derivative) @ $95.80 · Option exercise (M): 5,515 (derivative) @ $103.57 | EDGAR |
| 2026-11-12 | 4 | Plewman Patrick — SVP for Diagnostic Services | Option exercise (M): 4,274 @ $127.72 · Sale (S): 4,274 @ $257.34 · Option exercise (M): 6,793 @ $127.81 · Sale (S): 6,793 @ $257.34 · Sale (S): 650 @ $257.34 · Option exercise (M): 4,274 (derivative) @ $127.72 · +1 more | EDGAR |
| 2026-11-05 | 3 | Ramachandran Subu — SVP, Regional Businesses | Holdings only — no transactions reported | EDGAR |
| 2026-11-05 | 4 | DELANEY MARK E — SVP & Chief Commercial Officer | Grant/award (A): 2,615 @ $0 | EDGAR |
| 2026-11-05 | 4 | Doherty Catherine T. — Executive Vice President | Grant/award (A): 4,827 @ $0 · Option exercise (M): 22,105 @ $121.81 · Sale (S): 3,818 @ $245.45 · Sale (S): 5,990 @ $246.26 · Sale (S): 1,151 @ $246.98 · Sale (S): 2,358 @ $248.38 · +4 more | EDGAR |
| 2026-11-05 | 4 | Ramachandran Subu — SVP, Regional Businesses | Grant/award (A): 352 @ $0 · Grant/award (A): 1,386 (derivative) @ $0 | EDGAR |
| 2026-10-28 | 4 | PFEIFFER GARY M — Director | Sale (S): 1,203 @ $243 | EDGAR |
| 2026-10-23 | 4 | CARTER ROBERT B — Director | Code (L): 10 @ $235.93 | EDGAR |
| 2026-10-23 | 4 | Lassiter Wright III — Director | Code (L): 6 @ $235.96 | EDGAR |
| 2026-10-23 | 4 | KUPPUSAMY KARTHIK — SVP, Clinical Solutions | Code (L): 33 @ $235.94 | EDGAR |
| 2026-10-23 | 4 | Gregg Vicky B — Director | Grant/award (A): 63 @ $235.94 | EDGAR |
| 2026-10-23 | 4 | SAMAD SAM — Executive Vice President & CFO | Grant/award (A): 90 @ $235.94 | EDGAR |
| 2026-10-23 | 4 | DELANEY MARK E — SVP & Chief Commercial Officer | Code (L): 25 @ $235.94 | EDGAR |
| 2026-10-23 | 4 | MAIN TIMOTHY L — Director | Code (L): 18 @ $235.94 | EDGAR |
| 2026-10-23 | 4 | Plewman Patrick — SVP for Diagnostic Services | Code (L): 41 @ $235.94 | EDGAR |
| 2026-10-02 | 4 | WENTWORTH TIMOTHY C — Director | Grant/award (A): 135 (derivative) @ $0 | EDGAR |
| 2026-09-03 | 4 | Davis J. E. — CEO and President, Director | Sale (S): 10,000 @ $242.72 | EDGAR |
| 2026-08-31 | 4 | PREVOZNIK MICHAEL E — SVP & General Counsel | Option exercise (M): 22,677 @ $112.17 · Sale (S): 16,010 @ $242.88 · Sale (S): 6,237 @ $243.63 · Sale (S): 430 @ $244.51 · Gift (G): 1,000 @ $0 · Option exercise (M): 22,677 (derivative) @ $112.17 | EDGAR |
| 2026-07-29 | 4 | DELANEY MARK E — SVP & Chief Commercial Officer | Sale (S): 1,600 @ $235.18 | EDGAR |
| 2026-07-27 | 4 | CARTER ROBERT B — Director | Code (L): 11 @ $206.80 | EDGAR |
| 2026-07-27 | 4 | KUPPUSAMY KARTHIK — SVP, Clinical Solutions | Code (L): 37 @ $206.81 | EDGAR |
| 2026-07-27 | 4 | SAMAD SAM — Executive Vice President & CFO | Grant/award (A): 102 @ $206.81 | EDGAR |
| 2026-07-27 | 4 | MAIN TIMOTHY L — Director | Code (L): 21 @ $206.81 | EDGAR |
| 2026-07-27 | 4 | Plewman Patrick — SVP for Diagnostic Services | Code (L): 46 @ $206.81 | EDGAR |
| 2026-07-27 | 4 | Gregg Vicky B — Director | Grant/award (A): 72 @ $206.81 | EDGAR |
| 2026-07-27 | 4 | DELANEY MARK E — SVP & Chief Commercial Officer | Code (L): 34 @ $206.81 | EDGAR |
| 2026-07-27 | 4 | Lassiter Wright III — Director | Code (L): 6 @ $206.81 | EDGAR |
| 2026-07-02 | 4 | WENTWORTH TIMOTHY C — Director | Grant/award (A): 144 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | KUPPUSAMY KARTHIK — SVP, Clinical Solutions | Option exercise (M): 3,320 @ $127.72 · Option exercise (M): 4,827 @ $121.81 · Sale (S): 8,147 @ $200 · Option exercise (M): 3,320 (derivative) @ $127.72 · Option exercise (M): 4,827 (derivative) @ $121.81 | EDGAR |
| 2026-06-02 | 4 | Davis J. E. — CEO and President, Director | Sale (S): 10,000 @ $194.14 | EDGAR |
| 2026-05-21 | 4 | Lassiter Wright III — Director | Grant/award (A): 1,142 @ $0 | EDGAR |
| 2026-05-21 | 4 | Diaz Luis — Director | Grant/award (A): 1,142 @ $0 | EDGAR |
| 2026-05-21 | 4 | Doi Tracey — Director | Grant/award (A): 1,142 @ $0 | EDGAR |
| 2026-05-21 | 4 | Gregg Vicky B — Director | Grant/award (A): 1,142 @ $0 | EDGAR |
| 2026-05-21 | 4 | WENTWORTH TIMOTHY C — Director | Grant/award (A): 1,142 @ $0 | EDGAR |
| 2026-05-21 | 4 | MORRISON DENISE M — Director | Grant/award (A): 1,142 @ $0 | EDGAR |
| 2026-05-21 | 4 | RING TIMOTHY M — Director | Grant/award (A): 1,142 @ $0 | EDGAR |
| 2026-05-21 | 4 | CARTER ROBERT B — Director | Grant/award (A): 1,142 @ $0 | EDGAR |
| 2026-05-21 | 4 | MAIN TIMOTHY L — Director | Grant/award (A): 1,142 @ $0 | EDGAR |
| 2026-05-21 | 4 | PFEIFFER GARY M — Director | Grant/award (A): 1,142 @ $0 | EDGAR |
| 2026-04-24 | 4 | SAMAD SAM — Executive Vice President & CFO | Grant/award (A): 108 @ $194.70 | EDGAR |
| 2026-04-24 | 4 | Plewman Patrick — SVP for Diagnostic Services | Code (L): 49 @ $194.70 | EDGAR |
| 2026-04-24 | 4 | Gregg Vicky B — Director | Grant/award (A): 68 @ $194.70 | EDGAR |
| 2026-04-24 | 4 | CARTER ROBERT B — Director | Code (L): 7 @ $194.70 | EDGAR |
| 2026-04-24 | 4 | Lassiter Wright III — Director | Code (L): 6 @ $194.70 | EDGAR |
| 2026-04-24 | 4 | KUPPUSAMY KARTHIK — SVP, Clinical Solutions | Code (L): 39 @ $194.70 | EDGAR |
| 2026-04-24 | 4 | DELANEY MARK E — SVP & Chief Commercial Officer | Code (L): 37 @ $194.70 | EDGAR |
| 2026-04-02 | 4 | WENTWORTH TIMOTHY C — Director | Grant/award (A): 198 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | WENTWORTH TIMOTHY C — Director | Grant/award (A): 215 @ $0 | EDGAR |
| 2026-03-06 | 4 | KUPPUSAMY KARTHIK — SVP, Clinical Solutions | Grant/award (A): 6,200 @ $204.86 · Sale (S): 2,628 @ $204.86 | EDGAR |
Recent 8-K events — QUEST DIAGNOSTICS INC
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-22 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-22 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-10-06 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-07-23 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-21 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-08 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-01 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-21 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-10 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
GET https://api.filingpulse.io/v1/insider-trades?ticker=DGX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs